August 1988. Six weeks into residency, Dan was in James’s office by 9 A.M. sharp, every morning, double-headed scope already warmed.

“Thanks for this,” James said. “Previewing saves me.”

“No problem,” Dan said, eyes on the slide. “My chief did it for me. I’m paying it forward.” This was Dan’s straightest register—no riffs, no jokes.

“So why pathology?” James asked.

Dan kept scanning. “I was bored.”

“Huh?”

“First year of med school—gross anatomy is everyone’s darling. Cool, but it didn’t hook me. Physiology, biochem—felt like rehash. Almost quit. Second year we hit disease. Micro, pharm, path. That’s when it clicked. Third year I rotated in surgical pathology and never looked back.” He shifted a slide. “What about you? When’d it hit?”

January 1983.

James felt the room tilt toward another time.

“I was a third-year at the University of the Philippines,” he said. “Gunning for surgery like my father. Needed letters, perfect rotations—the whole performance. Then I went to an M&M.”

He could see it: the lecture hall, the donuts cooling in their box, the senior doctors in suits that made them look like strangers out of scrubs.

Dr. Ong, chief of surgery, stepped to the podium in a navy suit with faint pinstripes, yellow tie dotted lighter blue. “Welcome to January’s Morbidity and Mortality. We have a full list.”

First case: Luke Santiago, forty-five. Admitted with acute cholecystitis. Laparoscopic removal without complications. Post-op day one—fever to 102°F. Blood cultures: resistant staph; started on vancomycin. Fever persisted. Chest film with interstitial infiltrates. Infectious Disease consulted. Cultures negative. By day six—worsening, presumed septic shock. Bleeding gastric ulcer. Day twelve—death.

James, then a student, didn’t catch every protocol, but it was obvious: this was a tribunal. One by one, the treating services were called and cross-examined. Guilty in tone if not in word.

General surgery—guilty.

Infectious disease—guilty.

Hematology—guilty.

No diagnosis. Just blame.

“As in all complicated cases,” Dr. Ong said at last, “we turn to Dr. Torres, who performed the autopsy.”

Dr. Torres rose in a buttoned lab coat, red-striped tie neat against his collar. Mid-fifties, kind eyes, mestizo features softened by a few lines. James’s only exposure to pathologists until then was second-year lectures—ghosts behind slides. This was different.

Lights dimmed. The first image appeared: a gallbladder.

“This 52-gram gallbladder shows acute cholecystitis,” Dr. Torres said, voice even, “and numerous pigment stones, a clue to chronic hemolysis. Most stones are cholesterol, dietary. Pigment stones suggest red cell breakdown—thalassemia, sickle cell, other hemolytic processes—not considered clinically here.”

James leaned forward. A case he thought he understood had just pivoted.

“At autopsy,” Torres continued, “no dramatic gross findings beyond mild hepatosplenomegaly. But microscopically—” New images flashed: lung, liver, vasculature—vessels stuffed with malignant cells. “—nearly every organ shows intravascular tumor.”

James recognized malignant features, but not the source. Carcinoma? Lymphoma? Melanoma? Sarcoma? He chased labels and came up empty.

“The clue is subtle,” Torres said, advancing. “Faint brown pigment in the cytoplasm of some cells.”

The pigment was barely visible unless you sat in the front. Still, the room nodded as if proximity conferred understanding.

“I performed additional studies.” A blur of blue and brown followed as stains stacked the argument. Torres paused. “Lights.”

The room brightened. “This patient had metastatic malignant melanoma.”

A gasp moved through the hall—small, involuntary. No one had considered it. James felt his own breath catch.

“The pigment stones point to chronic hemolysis,” Torres said, “secondary not to infection but to low-grade DIC from widespread melanoma. Ongoing intravascular clotting consumes platelets and factors—bleeding worsens, ulcers bleed, red cells shear—hence pigment stones. The complications were not sepsis from the cholecystectomy. They were the malignancy’s wake.”

Dr. Ong stood. “Where was the primary melanoma?”

Torres smiled, already there. “After the autopsy findings, I performed a Wood’s lamp exam of the skin. Ultraviolet light revealed a lightly pigmented patch on the back. Biopsy showed features of a regressed melanoma. The immune system erased the visible primary, but the metastases remained.”

Murmurs rippled across the room. The case had unspooled backwards until the pattern locked into place.

“As always,” Ong said, returning to the mic, “it is the doctor’s doctor—the pathologist—who solves what confounds the rest of us.”

Doctor’s doctor.

James sat stunned. It wasn’t just the diagnosis—it was the way Torres had assembled the whole patient: pictures, labs, pathology, even a skin exam after death. A physician who read the body’s last story and told it cleanly. Not a technician. Not a consultant. A complete clinician.

“I told my father I wanted pathology after that,” James said softly, returning to 1988, to Dan, to the hum of the scope. “He was… not thrilled.”

“A bit?” Dan said, deadpan.

James smiled. “A lot.”

He leaned back, seeing again the Wood’s lamp glow, the faint patch on a back that told the truth no one else could see.

The call had been clear. The rest of his life would be the answering.

Next Chapter: Chapter 6-Exile